12 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 30655886 | Cancerous inhibitor of protein phosphatase 2A regulates cisplatin resistance in ovarian cancer. | 2019 Jan | 12 |
2 | 31612051 | Polyphyllin I and VII potentiate the chemosensitivity of A549/DDP cells to cisplatin by enhancing apoptosis, reversing EMT and suppressing the CIP2A/AKT/mTOR signaling axis. | 2019 Nov | 1 |
3 | 31703757 | Inhibitory effects of polyphyllins I and VII on human cisplatin-resistant NSCLC via p53 upregulation and CIP2A/AKT/mTOR signaling axis inhibition. | 2019 Oct | 1 |
4 | 29103022 | Increase in CIP2A expression is associated with cisplatin chemoresistance in gastric cancer. | 2018 Feb 6 | 1 |
5 | 30106121 | CIP2A depletion potentiates the chemosensitivity of cisplatin by inducing increased apoptosis in bladder cancer cells. | 2018 Nov | 1 |
6 | 30119963 | Polyphyllin I inhibits growth and invasion of cisplatin-resistant gastric cancer cells by partially inhibiting CIP2A/PP2A/Akt signaling axis. | 2018 Jul | 1 |
7 | 30410608 | CIP2A Promotes Proliferation, Invasion and Chemoresistance to Cisplatin in Renal Cell Carcinoma. | 2018 | 3 |
8 | 28534965 | Cucurbitacin B induces autophagy and apoptosis by suppressing CIP2A/PP2A/mTORC1 signaling axis in human cisplatin resistant gastric cancer cells. | 2017 Jul | 1 |
9 | 26404133 | CIP2A is associated with multidrug resistance in cervical adenocarcinoma by a P-glycoprotein pathway. | 2016 Feb | 1 |
10 | 26629248 | Knockdown of CIP2A sensitizes ovarian cancer cells to cisplatin: an in vitro study. | 2015 | 4 |
11 | 24293411 | Cancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancer. | 2014 Apr | 2 |
12 | 24874844 | Knockdown of cancerous inhibitor of protein phosphatase 2A may sensitize NSCLC cells to cisplatin. | 2014 May | 5 |